Search hospitals > Nebraska > Omaha

Children's Hospital and Medical Center of Omaha

Claim this profile
Omaha, Nebraska 68114
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Neuroblastoma
Conducts research for Soft Tissue Sarcoma
Conducts research for Osteosarcoma
197 reported clinical trials
7 medical researchers
Photo of Children's Hospital and Medical Center of Omaha in OmahaPhoto of Children's Hospital and Medical Center of Omaha in Omaha

Summary

Children's Hospital and Medical Center of Omaha is a medical facility located in Omaha, Nebraska. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Soft Tissue Sarcoma, Osteosarcoma and other specialties. Children's Hospital and Medical Center of Omaha is involved with conducting 197 clinical trials across 347 conditions. There are 7 research doctors associated with this hospital, such as Jill C. Beck, Minnie Abromowitch, Chittalsinh Raulji, MD, and Jeffrey Delaney, MD.

Area of expertise

1Cancer
Global Leader
Children's Hospital and Medical Center of Omaha has run 45 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II
2Brain Tumor
Global Leader
Children's Hospital and Medical Center of Omaha has run 39 trials for Brain Tumor. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Children's Hospital and Medical Center of Omaha

Brain Tumor
Testicular cancer
Wilms Tumor
Burkitt Lymphoma
Neuroblastoma
Cancer
Acute Lymphoblastic Leukemia
Leukemia
Biphenotypic Leukemia
Acute Leukemia
Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Recruiting1 award Phase 210 criteria
Image of trial facility.

Health Information Collection

for Childhood Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Recruiting1 award N/A10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Children's Hospital and Medical Center of Omaha?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security